Search

Your search keyword '"Rossing, Mary Anne"' showing total 955 results

Search Constraints

Start Over You searched for: Author "Rossing, Mary Anne" Remove constraint Author: "Rossing, Mary Anne"
955 results on '"Rossing, Mary Anne"'

Search Results

201. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer

202. Common variants at 19p13 are associated with susceptibility to ovarian cancer (vol 42, pg 880, 2010)

203. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

204. Population-based targeted sequencing of 54 candidate genes identifies PALB2as a susceptibility gene for high-grade serous ovarian cancer

205. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium

206. Abstract 2293: Oligomenorrhea, polycystic ovary syndrome, and risk of ovarian cancer histotypes, evidence from the Ovarian Cancer Association Consortium

207. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

208. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci

209. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies

210. Genome-wide significant risk associations for mucinous ovarian carcinoma (vol 47, pg 888, 2015)

211. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study.

212. A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome‐wide significant common variants.

213. Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.

214. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

215. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.

216. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

217. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.

218. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer:Evidence from the Ovarian Cancer Association Consortium

219. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk:Evidence from the Ovarian Cancer Association Consortium

220. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

221. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk

222. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)

223. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility:results from a large-scale collaboration

224. Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk:Candidate Genes, Obesity, and Hormone-Related Risk Factors

225. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer

226. Adult body mass index and risk of ovarian cancer by subtype:a Mendelian randomization study

227. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer:a pooled analysis of 18 case-control studies

229. Localization of a Susceptibility Gene for Familial Nonmedullary Thyroid Carcinoma to Chromosome 2q21

230. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer

231. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

232. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome

233. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium

234. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10

235. Risk Prediction for Epithelial Ovarian Cancer in 11 United States–Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci

236. No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

237. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk

238. Abstract 797: A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer

239. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies

240. Assessment of Multifactor Gene–Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors

241. A targeted genetic association study of epithelial ovarian cancer susceptibility

242. Evidence of a genetic link between endometriosis and ovarian cancer

243. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.

244. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

245. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes:Findings from the Ovarian Cancer Association Consortium

246. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

247. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

248. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

249. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

250. Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence.

Catalog

Books, media, physical & digital resources